Buscador de publicaciones

La producción científica de nuestros investigadores es muy elevada. En 2022 se publicaron 1.629 artículos en revistas científicas con un factor de impacto global que superó los 15.000 puntos.

A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors.

PMID: 36271011
Revista: Nature Communications
Año: 2022
Referencia: Nat Commun. 2022 Oct 21;13(1):6278. doi: 10.1038/s41467-022-33975-6.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Arribas, Ivan; Di Lernia, Davide; Diaz-Beveridge, Roberto; Gutierrez, Antonio; Hindi, Nadia; Ledesma, Patricio; Lopez-Martin, Jose Antonio; Lopez-Pousa, Antonio; Luna, Pablo; Marcilla, David et al.
DOI: 10.1038/s41467-022-33975-6

A Phase III, randomized, open-label study (CONTACT-02) of cabozantinib plus atezolizumab versus second novel hormone therapy in patients with metastatic castration-resistant prostate cancer.

PMID: 35034502
Revista: Future Oncology
Año: 2022
Referencia: Future Oncol. 2022 Mar;18(10):1185-1198. doi: 10.2217/fon-2021-1096. Epub 2022 Jan 17.
Factor de impacto: 3.404
Tipo de publicación: Artículo en revista internacional
Autores: McGregor, Bradley, Agarwal, Neeraj, Azad, Arun, Carles, Joan, Chowdhury, Simon, Saad, Fred, Soares, Andrey, Benzaghou, Fawzi, Kerloeguen, Yannick, Kimura, Akiko et al.
DOI: 10.2217/fon-2021-1096

A Phase III, randomized, open-label study (CONTACT-02) of cabozantinib plus atezolizumab versus second novel hormone therapy in patients with metastatic castration-resistant prostate cancer.

PMID: 35034502
Revista: Future Oncology
Año: 2022
Referencia: Future Oncol. 2022 Mar;18(10):1185-1198. doi: 10.2217/fon-2021-1096. Epub 2022 Jan 17.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Agarwal, Neeraj; Azad, Arun; Benzaghou, Fawzi; Carles, Joan; Chowdhury, Simon; Kerloeguen, Yannick; Kimura, Akiko; McGregor, Bradley; Merseburger, Axel S; Mohamed, Nehal et al.
DOI: 10.2217/fon-2021-1096

A phase-II study of atezolizumab in combination with obinutuzumab or rituximab for relapsed or refractory mantle cell or marginal zone lymphoma or Waldenstrom's macroglobulinemia.

PMID: 35045765
Revista: LEUKEMIA & LYMPHOMA
Año: 2022
Referencia: Leuk Lymphoma. 2022 May;63(5):1058-1069. doi: 10.1080/10428194.2021.2015765. Epub 2022 Jan 19.
Factor de impacto: 3.28
Tipo de publicación: Artículo en revista internacional
Autores: Willis, Jenna C, Buske, Christian, Perretti, Thomas, Katz, Pablo, Hamidi, Habib, Bottos, Alessia, Panayiotidis, Panayiotis, Tumyan, Gayane, Thieblemont, Catherine, Ptushkin, Vadim V et al.
DOI: 10.1080/10428194.2021.2015765

A phase-II study of atezolizumab in combination with obinutuzumab or rituximab for relapsed or refractory mantle cell or marginal zone lymphoma or Waldenstrom's macroglobulinemia.

PMID: 35045765
Revista: LEUKEMIA & LYMPHOMA
Año: 2022
Referencia: Leuk Lymphoma. 2022 May;63(5):1058-1069. doi: 10.1080/10428194.2021.2015765. Epub 2022 Jan 19.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Bottos, Alessia; Buske, Christian; Garcia-Sanz, Ramon; Hamidi, Habib; Katz, Pablo; Le Gouill, Steven; Marin-Niebla, Ana; Panayiotidis, Panayiotis; Perretti, Thomas; Ptushkin, Vadim V et al.
DOI: 10.1080/10428194.2021.2015765

A pilot study of circulating levels of TGF-beta1 and TGF-beta2 as biomarkers of bone healing in patients with non-hypertrophic pseudoarthrosis of long bones.

PMID: 34950754
Revista: Bone reports
Año: 2022
Referencia: Bone Rep. 2021 Dec 9;16:101157. doi: 10.1016/j.bonr.2021.101157. eCollection 2022 Jun.
Factor de impacto: 0
Tipo de publicación: Artículo en revista internacional
Autores: Chaverri, Daniel; Vivas, Daniel; Gallardo-Villares, Santiago; Granell-Escobar, Fernando; Pinto, Javier A; Vives, Joaquim et al.
DOI: 10.1016/j.bonr.2021.101157

A pilot study of circulating levels of TGF-beta1 and TGF-beta2 as biomarkers of bone healing in patients with non-hypertrophic pseudoarthrosis of long bones.

PMID: 34950754
Revista: Bone reports
Año: 2022
Referencia: Bone Rep. 2021 Dec 9;16:101157. doi: 10.1016/j.bonr.2021.101157. eCollection 2022 Jun.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Chaverri, Daniel; Gallardo-Villares, Santiago; Granell-Escobar, Fernando; Pinto, Javier A; Vivas, Daniel; Vives, Joaquim et al.
DOI: 10.1016/j.bonr.2021.101157

A Polygenic Risk Score Based on a Cardioembolic Stroke Multitrait Analysis Improves a Clinical Prediction Model for This Stroke Subtype.

PMID: 35872910
Revista: Frontiers in Cardiovascular Medicine
Año: 2022
Referencia: Front Cardiovasc Med. 2022 Jul 8;9:940696. doi: 10.3389/fcvm.2022.940696. eCollection 2022.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Alvarez-Sabin, Jose; Arenillas, Juan Francisco; Blay, Natalia; Campos, Francisco; Camps-Renom, Pol; Carcel-Marquez, Jara; Castillo, Jose; Cruchaga, Carlos; Cullell, Natalia; de Cid, Rafael et al.
DOI: 10.3389/fcvm.2022.940696

A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid.

PMID: 35309285
Revista: International Journal of Chronic Obstructive Pulmonary Disease
Año: 2022
Referencia: Int J Chron Obstruct Pulmon Dis. 2022 Mar 11;17:545-558. doi: 10.2147/COPD.S350167. eCollection 2022.
Factor de impacto: 3.355
Tipo de publicación: Artículo en revista internacional
Autores: Miravitlles, Marc, Verhamme, Katia, Calverley, Peter M A, Dreher, Michael, de la Hoz, Alberto, Wedzicha, Jadwiga, Price, David, Gardev, Asparuh, Bayer, Valentina et al.
DOI: 10.2147/COPD.S350167

A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid.

PMID: 35309285
Revista: International Journal of Chronic Obstructive Pulmonary Disease
Año: 2022
Referencia: Int J Chron Obstruct Pulmon Dis. 2022 Mar 11;17:545-558. doi: 10.2147/COPD.S350167. eCollection 2022.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Bayer, Valentina; Calverley, Peter M A; de la Hoz, Alberto; Dreher, Michael; Gardev, Asparuh; Miravitlles, Marc; Price, David; Verhamme, Katia; Wedzicha, Jadwiga et al.
DOI: 10.2147/COPD.S350167

A pragmatic randomized trial evaluating pre-operative aqueous antiseptic skin solutions in open fractures (Aqueous-PREP): statistical analysis plan.

PMID: 36096826
Revista: Trials
Año: 2022
Referencia: Trials. 2022 Sep 12;23(1):772. doi: 10.1186/s13063-022-06541-0.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Abbott, Harper; Acerboni-Flores, Francesc; Achor, Timothy S; Adams, John D; Ahn, James S; Al-Asiri, Jamal; Alavedra-Massana, Anna; Alnasser, Ahmad; Altman, Kyle M; Amirhekmat, Arya et al.
DOI: 10.1186/s13063-022-06541-0

A Preclinical and Phase Ib Study of Palbociclib plus Nab-Paclitaxel in Patients with Metastatic Adenocarcinoma of the Pancreas.

PMID: 36970055
Revista: Cancer research communications
Año: 2022
Referencia: Cancer Res Commun. 2022 Nov 2;2(11):1326-1333. doi: 10.1158/2767-9764.CRC-22-0072. eCollection 2022 Nov.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Borazanci, Erkut; Garcia-Carbonero, Rocio; Garrido-Laguna, Ignacio; Grossman, Joseph E; Hidalgo, Manuel; Huang, Xin; Kern, Kenneth; Laheru, Daniel; Lim, Kian-Huat; Lowy, Andrew M et al.
DOI: 10.1158/2767-9764.CRC-22-0072

A Prospective, Multicenter Study of Closed System Extracorporeal Photopheresis for Children With Steroid-Refractory Acute Graft-Versus-Host Disease.

PMID: 35124293
Revista: Transplantation and cellular therapy
Año: 2022
Referencia: Transplant Cell Ther. 2022 May;28(5):261.e1-261.e7. doi: 10.1016/j.jtct.2022.01.025. Epub 2022 Feb 4.
Factor de impacto: 0
Tipo de publicación: Artículo en revista internacional
Autores: Kitko, Carrie L; Abdel-Azim, Hisham; Carpenter, Paul A; Dalle, Jean-Hugues; Diaz-de-Heredia, Cristina; Gaspari, Stefania; Gennery, Andrew R; Handgretinger, Rupert; Lawitschka, Anita et al.
DOI: 10.1016/j.jtct.2022.01.025

A Prospective, Multicenter Study of Closed System Extracorporeal Photopheresis for Children With Steroid-Refractory Acute Graft-Versus-Host Disease.

PMID: 35124293
Revista: Transplantation and Cellular Therapy
Año: 2022
Referencia: Transplant Cell Ther. 2022 May;28(5):261.e1-261.e7. doi: 10.1016/j.jtct.2022.01.025. Epub 2022 Feb 4.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Abdel-Azim, Hisham; Carpenter, Paul A; Dalle, Jean-Hugues; Diaz-de-Heredia, Cristina; Gaspari, Stefania; Gennery, Andrew R; Handgretinger, Rupert; Kitko, Carrie L; Lawitschka, Anita et al.
DOI: 10.1016/j.jtct.2022.01.025

A Prospective, Real-World, Multinational Study of Naloxegol for Patients with Cancer Pain Diagnosed with Opioid-Induced Constipation-The NACASY Study.

PMID: 35267436
Revista: Cancers
Año: 2022
Referencia: Cancers (Basel). 2022 Feb 23;14(5). pii: cancers14051128. doi: 10.3390/cancers14051128.
Factor de impacto: 6.639
Tipo de publicación: Artículo en revista internacional
Autores: Davies, Andrew, Cinieri, Saverio, Dupoiron, Denis, Espana Fernandez, Sofia, Leclerc, Johan, Montesarchio, Vincenzo, Mystakidou, Kyriaki, Serna, Judith, Tack, Jan, On Behalf Of The Nacasy Study Group et al.
DOI: 10.3390/cancers14051128

A Prospective, Real-World, Multinational Study of Naloxegol for Patients with Cancer Pain Diagnosed with Opioid-Induced Constipation-The NACASY Study.

PMID: 35267436
Revista: Cancers
Año: 2022
Referencia: Cancers (Basel). 2022 Feb 23;14(5). pii: cancers14051128. doi: 10.3390/cancers14051128.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Cinieri, Saverio; Davies, Andrew; Dupoiron, Denis; Espana Fernandez, Sofia; Leclerc, Johan; Montesarchio, Vincenzo; Mystakidou, Kyriaki; On Behalf Of The Nacasy Study Group; Serna, Judith; Tack, Jan et al.
DOI: 10.3390/cancers14051128

A Randomised Controlled Trial to Assess the Benefit of Posterior Rhabdosphincter Reconstruction in Early Urinary Continence Recovery after Robot-assisted Radical Prostatectomy.

PMID: 33653674
Revista: European Urology Oncology
Año: 2022
Referencia: Eur Urol Oncol. 2022 Aug;5(4):460-463. doi: 10.1016/j.euo.2021.02.005. Epub 2021 Feb 27.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Celma, Anna; Morote, Juan; Planas, Jacques; Regis, Lucas; Salazar, Aina; Santamaria, Anna; Trilla, Enrique et al.
DOI: 10.1016/j.euo.2021.02.005

A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial).

PMID: 36335783
Revista: EUROPEAN JOURNAL OF CANCER
Año: 2022
Referencia: Eur J Cancer. 2022 Dec;177:154-163. doi: 10.1016/j.ejca.2022.09.037. Epub 2022 Oct 14.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Aranda, E; Aranda, Enrique; Argiles; Argiles, Guillem; Argiles, Guillem; Argiles, Guillem; Benavides, M; Benavides, Manuel; Bennouna, J; Bennouna, Jaafar et al.
DOI: 10.1016/j.ejca.2022.09.037

A randomized controlled trial of liposomal cyclosporine A for inhalation in the prevention of bronchiolitis obliterans syndrome following lung transplantation.

PMID: 34587371
Revista: AMERICAN JOURNAL OF TRANSPLANTATION
Año: 2022
Referencia: Am J Transplant. 2022 Jan;22(1):222-229. doi: 10.1111/ajt.16858. Epub 2021 Oct 18.
Factor de impacto: 8.086
Tipo de publicación: Artículo en revista internacional
Autores: Knoop, Christiane; Jaksch, Peter; Parmar, Jasvir; Ussetti, Piedad; Sole, Amparo; Muller-Quernheim, Joachim; Kessler, Romain; Wirtz, Hubert; Boerner, Gerhard; Denk, Oliver et al.
DOI: 10.1111/ajt.16858

A randomized controlled trial of liposomal cyclosporine A for inhalation in the prevention of bronchiolitis obliterans syndrome following lung transplantation.

PMID: 34587371
Revista: AMERICAN JOURNAL OF TRANSPLANTATION
Año: 2022
Referencia: Am J Transplant. 2022 Jan;22(1):222-229. doi: 10.1111/ajt.16858. Epub 2021 Oct 18.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Behr, Juergen; Boerner, Gerhard; Denk, Oliver; Ghiani, Alessandro; Jaksch, Peter; Kessler, Romain; Kneidinger, Nikolaus; Knoop, Christiane; Monforte, Victor; Muller-Quernheim, Joachim et al.
DOI: 10.1111/ajt.16858

A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg per Day Compared with the Cabozantinib Capsule at 140 mg per Day in Patients With Progressive, Metastatic Medullary Thyroid Cancer.

PMID: 35403447
Revista: THYROID
Año: 2022
Referencia: Thyroid. 2022 May;32(5):515-524. doi: 10.1089/thy.2022.0027.
Factor de impacto: 6.568
Tipo de publicación: Artículo en revista internacional
Autores: Badiu, Corin, Robinson, Bruce, Hughes, Brett G M, Keam, Bhumsuk, Parnis, Francis, Elisei, Rossella, Gajate, Pablo, Gan, Hui K, Kapiteijn, Ellen, Locati, Laura et al.
DOI: 10.1089/thy.2022.0027

A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg per Day Compared with the Cabozantinib Capsule at 140 mg per Day in Patients With Progressive, Metastatic Medullary Thyroid Cancer.

PMID: 35403447
Revista: THYROID
Año: 2022
Referencia: Thyroid. 2022 May;32(5):515-524. doi: 10.1089/thy.2022.0027.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Badiu, Corin; Capdevila, Jaume; Elisei, Rossella; Faoro, Leonardo; Gajate, Pablo; Gan, Hui K; Hughes, Brett G M; Isaev, Pavel; Jarzab, Barbara; Kapiteijn, Ellen et al.
DOI: 10.1089/thy.2022.0027

A randomized phase II study comparing consolidation with a single dose of (90)Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results.

PMID: 34459702
Revista: LEUKEMIA & LYMPHOMA
Año: 2022
Referencia: Leuk Lymphoma. 2022 Jan;63(1):93-100. doi: 10.1080/10428194.2021.1971216. Epub 2021 Aug 30.
Factor de impacto: 3.28
Tipo de publicación: Artículo en revista internacional
Autores: Canales, Miguel Angel; Lopez-Guillermo, Armando; Tomas, Jose Francisco; Briones, Javier; Martin Garcia-Sancho, Alejandro; Sancho, Juan Manuel; Moraleda, Jose Maria; Terol, Maria Jose; Salar, Antonio; Palomera, Luis et al.
DOI: 10.1080/10428194.2021.1971216

A randomized phase II study comparing consolidation with a single dose of (90)Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results.

PMID: 34459702
Revista: LEUKEMIA & LYMPHOMA
Año: 2022
Referencia: Leuk Lymphoma. 2022 Jan;63(1):93-100. doi: 10.1080/10428194.2021.1971216. Epub 2021 Aug 30.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Bargay, Joan; Briones, Javier; Canales, Miguel Angel; Conde, Eulogio; Deben, Guillermo; Dlouhy, Ivan; Ferrer, Secundino; Garcia Marco, Jose A; Gardella, Santiago; Hernandez, Miguel T et al.
DOI: 10.1080/10428194.2021.1971216

Publicaciones

Buscador de publicaciones

A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors.

A Phase III, randomized, open-label study (CONTACT-02) of cabozantinib plus atezolizumab versus second novel hormone therapy in patients with metastatic castration-resistant prostate cancer.

A Phase III, randomized, open-label study (CONTACT-02) of cabozantinib plus atezolizumab versus second novel hormone therapy in patients with metastatic castration-resistant prostate cancer.

A phase-II study of atezolizumab in combination with obinutuzumab or rituximab for relapsed or refractory mantle cell or marginal zone lymphoma or Waldenstrom's macroglobulinemia.

A phase-II study of atezolizumab in combination with obinutuzumab or rituximab for relapsed or refractory mantle cell or marginal zone lymphoma or Waldenstrom's macroglobulinemia.

A pilot study of circulating levels of TGF-beta1 and TGF-beta2 as biomarkers of bone healing in patients with non-hypertrophic pseudoarthrosis of long bones.

A pilot study of circulating levels of TGF-beta1 and TGF-beta2 as biomarkers of bone healing in patients with non-hypertrophic pseudoarthrosis of long bones.

A Polygenic Risk Score Based on a Cardioembolic Stroke Multitrait Analysis Improves a Clinical Prediction Model for This Stroke Subtype.

A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid.

A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid.

A pragmatic randomized trial evaluating pre-operative aqueous antiseptic skin solutions in open fractures (Aqueous-PREP): statistical analysis plan.

A Preclinical and Phase Ib Study of Palbociclib plus Nab-Paclitaxel in Patients with Metastatic Adenocarcinoma of the Pancreas.

A Prospective, Multicenter Study of Closed System Extracorporeal Photopheresis for Children With Steroid-Refractory Acute Graft-Versus-Host Disease.

A Prospective, Multicenter Study of Closed System Extracorporeal Photopheresis for Children With Steroid-Refractory Acute Graft-Versus-Host Disease.

A Prospective, Real-World, Multinational Study of Naloxegol for Patients with Cancer Pain Diagnosed with Opioid-Induced Constipation-The NACASY Study.

A Prospective, Real-World, Multinational Study of Naloxegol for Patients with Cancer Pain Diagnosed with Opioid-Induced Constipation-The NACASY Study.

A Randomised Controlled Trial to Assess the Benefit of Posterior Rhabdosphincter Reconstruction in Early Urinary Continence Recovery after Robot-assisted Radical Prostatectomy.

A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial).

A randomized controlled trial of liposomal cyclosporine A for inhalation in the prevention of bronchiolitis obliterans syndrome following lung transplantation.

A randomized controlled trial of liposomal cyclosporine A for inhalation in the prevention of bronchiolitis obliterans syndrome following lung transplantation.

A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg per Day Compared with the Cabozantinib Capsule at 140 mg per Day in Patients With Progressive, Metastatic Medullary Thyroid Cancer.

A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg per Day Compared with the Cabozantinib Capsule at 140 mg per Day in Patients With Progressive, Metastatic Medullary Thyroid Cancer.

A randomized phase II study comparing consolidation with a single dose of (90)Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results.

A randomized phase II study comparing consolidation with a single dose of (90)Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results.

Patronato:

Colabora:

Acreditaciones: